Yüklüyor......
The contribution of -arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: a review of rtPA neurotoxicity
Alteplase is the only drug licensed for acute ischemic stroke, and in this formulation, the thrombolytic agent recombinant tissue plasminogen activator (rtPA) is stabilized in a solution of -arginine. Improved functional outcomes after alteplase administration have been shown in clinical trials, alo...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Nature Publishing Group
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3023931/ https://ncbi.nlm.nih.gov/pubmed/20736961 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jcbfm.2010.149 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|